ARK Diagnostics, Inc. products

The ARK™ Gabapentin Assay is intended for the quantitative determination of Gabapentin in human serum or plasma on automated clinical chemistry analyzers. Gabapentin concentrations can be used as an aid in management of patients treated with gabapentin.

The ARK Lacosamide Assay is intended for the quantitative determination of lacosamide in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of lacosamide to help ensure appropriate therapy.

The ARK™ Lamotrigine Assay is intended for the quantitative determination of Lamotrigine in human serum or plasma on automated clinical chemistry analyzers. Lamotrigine concentrations can be used as an aid in management of patients treated with lamotrigine.

The ARK AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PINACA and its metabolites in human urine at a cutoff concentration of 5 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers.

The ARK UR-144/JWH-018 Assay is an immunoassay intended for the qualitative determination of UR-144, JWH-018, and their metabolites in human urine at a cutoff concentration of 10 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers.

The ARK EDDP Assay is an immunoassay intended for the qualitative and/or semiquantitative determination of EDDP in human urine at cutoff concentrations of 100 ng/mL and 300 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers. This in vitro diagnostic device is for prescription use only.

The ARK Methotrexate Assay is intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of methotrexate to help ensure appropriate therapy.

The ARK Efavirenz Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of efavirenz in human serum or plasma on automated clinical chemistry analyzers. The serum or plasma concentration of efavirenz, used in combination with other clinical information, may aid in the management of patients treated with efavirenz. Measurements of efavirenz are intended to help ensure appropriate therapy or to monitor adherence.

The ARK Linezolid Assay is intended for the quantitative determination of linezolid in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of linezolid to help ensure appropriate therapy.

The ARK Voriconazole II Assay is intended for the quantitative determination of voriconazole in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of voriconazole to help ensure appropriate therapy.